These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11394663)

  • 1. Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus.
    Valla DC; Degos F
    J Hepatol; 2001 Apr; 34(4):606-9. PubMed ID: 11394663
    [No Abstract]   [Full Text] [Related]  

  • 2. Interferon and hepatocellular carcinoma.
    Koretz RL
    Lancet; 1996 Jan; 347(8995):194-5. PubMed ID: 8544565
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multicenter study on the inhibition of hepatocarcinogenesis by interferon therapy (IHIT)].
    Yoshida H; Omata M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):463-6. PubMed ID: 15359842
    [No Abstract]   [Full Text] [Related]  

  • 4. The oncogenic hepatitis C virus and direct-acting antivirals: economic implications for hepatocellular carcinoma in Medicaid beneficiaries with cirrhosis.
    Mantravadi S
    Am J Manag Care; 2017 Apr; 23(5 Spec No.):SP180-SP184. PubMed ID: 28665676
    [No Abstract]   [Full Text] [Related]  

  • 5. [Does interferon therapy on type C liver cirrhosis prevent the occurrence of hepatocellular carcinoma?].
    Harada H; Iga D; Arisaka Y; Mitsuhashi Y; Kamitsukasa H; Yagura M; Endou H; Kawashima H
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):754-8. PubMed ID: 7563870
    [No Abstract]   [Full Text] [Related]  

  • 6.  Ongoing alcohol consumptions counteracts the benefits of sustained virological response in patients with well compensated hepatitis C cirrhosis: an observational study.
    Hernaez R; El-Serag H
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):16-20. PubMed ID: 28051790
    [No Abstract]   [Full Text] [Related]  

  • 7. Can interferon prevent hepatocellular carcinoma in hepatitis C virus-induced cirrhosis?
    Grimm I; Shaheen N
    Gastroenterology; 1996 Jun; 110(6):2019-21. PubMed ID: 8964437
    [No Abstract]   [Full Text] [Related]  

  • 8. Antiviral treatment for cirrhosis due to hepatitis C: a review.
    Somasundaram A; Venkataraman J
    Singapore Med J; 2012 Apr; 53(4):231-5. PubMed ID: 22511042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does surveillance for hepatocellular carcinoma benefit patients with compensated cirrhosis?
    Yopp A; Waljee A; Singal AG
    Gastroenterology; 2014 Oct; 147(4):935-6. PubMed ID: 25150788
    [No Abstract]   [Full Text] [Related]  

  • 10. Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
    Mazzella G; Accogli E; Sottili S; Festi D; Orsini M; Salzetta A; Novelli V; Cipolla A; Fabbri C; Pezzoli A; Roda E
    J Hepatol; 1996 Feb; 24(2):141-7. PubMed ID: 8907566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of recurrence of hepatocellular carcinoma with anti-viral therapy for hepatitis C virus].
    Aikata H; Chayama K
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():311-5. PubMed ID: 26845951
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply: To PMID 24677195.
    Mourad A; Mathurin P; Deuffic-Burban S
    Gastroenterology; 2014 Oct; 147(4):936-7. PubMed ID: 25150789
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma.
    Kumada H
    Oncology; 2002; 62 Suppl 1():94-100. PubMed ID: 11868794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Does antiviral therapy improve the clinical course of cirrhosis due to hepatitis C virus infection?].
    Diago M
    Gastroenterol Hepatol; 2007 Feb; 30(2):85-92. PubMed ID: 17335716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevention for the development of hepatitis B virus-related hepatocellular carcinoma by anti-viral treatment].
    Ebinuma H; Saito H
    Nihon Rinsho; 2011 May; 69 Suppl 4():540-5. PubMed ID: 22096977
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
    Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
    Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perspective: incision revision.
    Schwartz M
    Nature; 2014 Dec; 516(7529):S17. PubMed ID: 25470196
    [No Abstract]   [Full Text] [Related]  

  • 18. Current strategies for chemoprevention of hepatocellular carcinoma.
    Okita K; Sakaida I; Hino K
    Oncology; 2002; 62 Suppl 1():24-8. PubMed ID: 11868781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusually High Rates of Hepatocellular Carcinoma After Treatment With Direct-Acting Antiviral Therapy for Hepatitis C Related Cirrhosis.
    Ravi S; Axley P; Jones D; Kodali S; Simpson H; McGuire BM; Singal AK
    Gastroenterology; 2017 Mar; 152(4):911-912. PubMed ID: 28161225
    [No Abstract]   [Full Text] [Related]  

  • 20. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.